Home › Trial NCT01284608
Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)
- Trial IDNCT01284608
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorAstraZeneca
- Enrollment197
- Start date2011-03
- ConditionsProstatic Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.